Skip to Content

Amiodarone Hydrochloride Injection

Last Updated: October 2, 2014
Status: Resolved

Products Affected - Description

There are no products affected.

Reason for the Shortage

  • Hospira had amiodarone injection on shortage due to manufacturing delays.
  • Fresenius Kabi had amiodarone injection on shortage due to increased demand.
  • West-Ward stated the reason for the shortage was demand exceeding supply due to current market conditions.

Available Products

Amiodarone 50 mg/mL injection, Fresenius Kabi
3 mL vials, package of 10 (NDC 63323-0616-03)

9 mL vials, package of 10 (NDC 63323-0616-09)
 
Amiodarone 50 mg/mL injection, Hospira
3 mL ampules, package of 10 (NDC 00409-4348-35)

Amiodarone 50 mg/mL injection, Mylan Institutional
3 mL vials, package of 10 (NDC 67457-0153-03)
9 mL vials, package of 10 (NDC 67457-0153-09)
18 mL vials, package of 1 (NDC 67457-0153-18)

Amiodarone 50 mg/mL injection, Sagent
3 mL syringes (NDC 25021-0302-66)
 
Amiodarone 50 mg/mL injection, West-Ward
3 mL vial, package of 10 (NDC 00143-9875-10)
 
Nexterone premixed injection, Baxter
150 mg/100 mL premixed bags (NDC 43066-0150-10)
360 mg/200 mL premixed bags (NDC 43066-0360-20)

Estimated Resupply Dates

All presentations are available.

Related Shortages

Updated

October 2, 2014; September 22, 2014; August 21, 2014; July 17, 2014; June 26, 2014; June 12, 2014; May 27, 2014; May 12, 2014; May 8, 2014, University of Utah, Drug Information Service. Copyright 2014, University of Utah, Drug Information Service.

Hide